drugset / Trial / NCT06679959
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of ASC30 Injection in Participants With Obesity
RandomizedSequentialQuadruple-blindTreatment
Summary
This randomized, double-blind, placebo-controlled single ascending dose (SAD)/ multiple ascending dose (MAD) study is designed to evaluate the safety, tolerability, pharmacokinetics, and efficacy of ASC30 injection
Timeline
- Start
- 2024-09-16
- Primary completion
- 2026-03-26
- Completion
- 2026-03-26
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ASC30 | Unknown | — | Subcutaneous |
Indications
No indication recorded.